Find where to buy products from suppliers in the USA, including: distributors, industrial manufacturers in America, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the American suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the UK.
| Product | Description | |
|---|---|---|
| CYCLODEXTRIN | Heterocyclic Organic Compound. CAS No. 12619-70-4. Catalog: ACM12619704. |  |
| Cyclodextrin Glucanotransferase (Crude Enzyme) | In enzymology, a cyclomaltodextrin glucanotransferase is an enzyme that catalyzes the chemical reaction of cyclizing part of a 1,4-alpha-D-glucan molecule through the formation of a 1,4-alpha-D-glucosidic bond. This enzyme belongs to the family of glycosyltransferases, specifically the hexosyltransferases. This product with the indicated enzyme activity was briefly purified from engineered E. coli. Applications: Industry; synthesis; nutrition; pharmacology. Group: Enzymes. Synonyms: Bacillus macerans amylase; cyclodextrin glucanotransfera. Enzyme Commission Number: EC 2.4.1.19. CAS No. 9030-9-5. Activity: Undetermined. Appearance: Clear to translucent yellow solution. Storage: at -20 °C or lower, for at least 1 month. Source: E. coli. Bacillus macerans amylase; cyclodextrin glucanotransferase; α-cyclodextrin glucanotransferase; α-cyclodextrin glycosyltransferase; β-cyclodextrin glucanotransferase; β-cyclodextrin glycosyltransferase; γ-cyclodextrin glycosyltransferase; cyclodextrin glycosyltransferase; cyclomaltodextrin glucotransferase; cyclomaltodextrin glycosyltransferase; konchizaimu; α-1,4-glucan 4-glycosyltransferase, cyclizing; BMA; CGTase; neutral-cyclodextrin glycosyltransferase; 1,4-α-D-glucan 4-α-D-(1,4-α-D-glucano)-transferase (cyclizing). Pack: 100ml. Cat No: NATE-1812. |  |
| Cyclodextrins | Cyclodextrins occur as white, practically odorless, fine crystalline powders, having a slightly sweet taste. Some cyclodextrin derivatives occur as amorphous powders. Synonyms: Cavitron; cyclic oligosaccharide; cycloamylose; cycloglucan; Encapsin; Schardinger dextrin. Product ID: PE-0591. Category: Solubilizing Agents; Stabilizing Agents. Product Keywords: Stabilizers; Solubilizer Excipients; PE-0591; Cyclodextrins; Solubilizing Agents; Stabilizing Agents;. UNII: Z1LH97KTRM. Grade: Pharmceutical Excipients. Administration route: α-cyclodextrin (injection); β-cyclodextrin (oral; topical); γ-cyclodextrin (IV injections). Dosage Form: α-cyclodextrin (injection preparations); β-cyclodextrin (oral tablets, topical gels); γ-cyclodextrin (IV injections). Stability and Storage Conditions: β-Cyclodextrin and other cyclodextrins are stable in the solid state if protected from high humidity. Cyclodextrins should be stored in a tightly sealed container, in a cool, dry place. Source and Preparation: Cyclodextrins are manufactured by the enzymatic degradation of starch using specialized bacteria. For example, b-cyclodextrin is produced by the action of the enzyme cyclodextrin glucosyltransferase upon starch or a starch hydrolysate. An organic solvent is used to direct the reaction that produces b-cyclodextrin, and to prevent the growth of microorganisms during the enzymatic reaction. The inso |  |
| 1,1,1-Tris[4-(per-O-methyl-α-cyclodextrin-6-yloxy)phenyl]ethane | 1,1,1-Tris[4-(per-O-methyl-α-cyclodextrin-6-yloxy)phenyl]ethane. Group: Supramolecular host materials. |  |
| 1,1,1-Tris[4-(per-O-methyl-alpha-cyclodextrin-6-yloxy)phenyl]ethane | 1,1,1-Tris[4-(per-O-methyl-alpha-cyclodextrin-6-yloxy)phenyl]ethane. Group: Macrocycles. Product ID: 5-[4-[1, 1-bis[4-[[31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42-dodecamethoxy-10, 15, 20, 25, 30-pentakis(methoxymethyl)-2, 4, 7, 9, 12, 14, 17, 19, 22, 24, 27, 29-dodecaoxaheptacyclo[26.2.2.23, 6.28, 11.213, 16.218, 21.223, 26]dotetracontan-5-yl]oxy]phenyl]ethyl]phenoxy]-31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42-dodecamethoxy-10, 15, 20, 25, 30-pentakis(methoxymethyl)-2, 4, 7, 9, 12, 14, 17, 19, 22, 24, 27, 29-dodecaoxaheptacyclo[26.2.2.23, 6.28, 11.213, 16.218, 21.223, 26]dotetracontane. Molecular formula: 3844g/mol. Mole weight: C176H288O90. CC (C1=CC=C (C=C1) OC2C3C (C (C (O2) OC4C (OC (C (C4OC) OC) OC5C (OC (C (C5OC) OC) OC6C (OC (C (C6OC) OC) OC7C (OC (C (C7OC) OC) OC8C (OC (O3) C (C8OC) OC) COC) COC) COC) COC) COC) OC) OC) (C9=CC=C (C=C9) OC1C2C (C (C (O1) OC1C (OC (C (C1OC) OC) OC1C (OC (C (C1OC) OC) OC1C (OC (C (C1OC) OC) OC1C (OC (C (C1OC) OC) OC1C (OC (O2) C (C1OC) OC) COC) COC) COC) COC) COC) OC) OC) C1=CC=C (C=C1) OC1C2C (C (C (O1) OC1C (OC (C (C1OC) OC) OC1C (OC (C (C1OC) OC) OC1C (OC (C (C1OC) OC) OC1C (OC (C (C1OC) OC) OC1C (OC (O2) C (C1OC) OC) COC) COC) COC) COC) COC) OC) OC. InChI=1S/C176H288O90/c1-176 (80-53-59-83 (60-54-80)228-173-152-131 (207-32)149 (225-50)170 (264-173)258-113-98 (77-189-14)240-164 (143 (219-44)128 (113)204-29)252-107-92 (71- | |
| 2,2-Bis[4-(per-O-methyl-α-cyclodextrin-6-yloxy)phenyl]propane | 2,2-Bis[4-(per-O-methyl-α-cyclodextrin-6-yloxy)phenyl]propane. Group: Supramolecular host materials. | |
| 2,2-Bis[4-(per-O-methyl-alpha-cyclodextrin-6-yloxy)phenyl]propane | 2,2-Bis[4-(per-O-methyl-alpha-cyclodextrin-6-yloxy)phenyl]propane. Group: Macrocycles. Product ID: 5-[[4-[2-[4-[[20, 25-diethoxy-31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42-dodecamethoxy-10, 15, 30-tris(methoxymethyl)-2, 4, 7, 9, 12, 14, 17, 19, 22, 24, 27, 29-dodecaoxaheptacyclo[26.2.2.23, 6.28, 11.213, 16.218, 21.223, 26]dotetracontan-5-yl]methoxy]phenyl]propan-2-yl]phenyl]methoxymethyl]-31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42-dodecamethoxy-10, 15, 20, 25, 30-pentakis(methoxymethyl)-2, 4, 7, 9, 12, 14, 17, 19, 22, 24, 27, 29-dodecaoxaheptacyclo[26.2.2.23, 6.28, 11.213, 16.218, 21.223, 26]dotetracontane. Molecular formula: 2628.9g/mol. Mole weight: C122H202O60. CCOC1C2C (C (C (O1) OC3C (C (C (OC4C (OC (C (C4OC) OC) OC5C (OC (C (C5OC) OC) OC6C (OC (C (C6OC) OC) OC7C (OC (O2) C (C7OC) OC) COC) COC8=CC=C (C=C8) C (C) (C) C9=CC=C (C=C9) COCC1C2C (C (C (O1) OC1C (OC (C (C1OC) OC) OC1C (OC (C (C1OC) OC) OC1C (OC (C (C1OC) OC) OC1C (OC (C (C1OC) OC) OC1C (OC (O2) C (C1OC) OC) COC) COC) COC) COC) COC) OC) OC) COC) COC) OC3OCC) OC) OC) OC) OC. InChI=1S / C122H202O60 / c1-37-156-108-106-93 (142-24) 105 (154-36) 121 (182-108) 180-107-92 (141-23) 104 (153-35) 120 (181-109 (107) 157-38-2) 178-79-69 (55-130-12) 165-114 (100 (149-31) 89 (79) 138-20) 173-76-66 (52-127-9) 164-116 (99 (148-30) 86 (76) 135-17) 177-81-71 (168-118 (102 (151-33) 91 (81) 140-22) 175-78-68 (54-129-11) | |
| 2,3,6-Triethyl-gamma-cyclodextrin | 2,3,6-Triethyl-gamma-cyclodextrin is a modified cyclodextrin utilized in drug delivery systems to increase solubility and stability of drugs. It plays a critical role in enhancing the bioavailability of poorly water-soluble drugs, thereby improving therapeutic effectiveness. Synonyms: Octakis-(2,3,6-tri-O-ethyl)-γ-cyclodextrin. Molecular formula: C95H176O40. Mole weight: 1958.39. |  |
| 2,3,6-Trimethyl-gamma-cyclodextrin | 2,3,6-Trimethyl-gamma-cyclodextrin is a modified cyclodextrin used in the biomedical industry to enhance the water-solubility of poorly soluble drugs, expanding their bioavailability. It is commonly used in drug-delivery systems research of various therapeutic applications. Synonyms: Heptakis-(2,3,6-tri-O-methyl)-γ-cyclodextrin. Molecular formula: C70H124O42. Mole weight: 1637.71. | |
| 2,3,6-Tri-O-acetyl-gamma-cyclodextrin | 2,3,6-Tri-O-acetyl-gamma-cyclodextrin is a medically significant cyclodextrin derivative. It enhances the solubility and stability of poorly soluble pharmaceuticals, especially relevant in the development of anti-cancer and cardiovascular medicines, thereby contributing to drug delivery improvement. Synonyms: Octakis-(2,3,6-tri-O-acetyl)-γ-cyclodextrin. Molecular formula: C96H128O64. Mole weight: 2306.01. | |
| 2,3,6-Tri-O-benzoyl-gamma-cyclodextrin | 2,3,6-Tri-O-benzoyl-gamma-cyclodextrin is a pharmaceutical intermediate extensively used in the biomedical research for the development and synthesis of drugs. It aids in improving drug solubility and bioavailability, enhancing the performance of drugs with poor permeability. Synonyms: Octakis-(2,3,6-tri-O-benzoyl)-γ-cyclodextrin. Molecular formula: C216H176O64. Mole weight: 3795.67. | |
| 2,3,6-Tri-O-benzyl-gamma-cyclodextrin | 2,3,6-Tri-O-benzyl-gamma-cyclodextrin is a modified cyclodextrin derivative utilized widely in the pharmaceutical industry. It plays a role in drug delivery by enhancing solubility and stability of poorly water-soluble drugs, thereby improving their bioavailability. Synonyms: Octakis-(2,3,6-tri-O-benzyl)-γ-cyclodextrin. Molecular formula: C216H224O40. Mole weight: 3460.07. | |
| 2,3,6-Trioctyl-gamma-cyclodextrin | 2,3,6-Trioctyl-gamma-cyclodextrin is a synthetic derivative of gamma-cyclodextrin. It's a bioactive compound primarily used in pharmaceutical industry as a drug delivery molecule, improving the solubility and stability of poorly water-soluble drugs. Synonyms: Octakis-(2,3,6-tri-O-n-octyl)-γ-cyclodextrin. Molecular formula: C240H464O40. Mole weight: 3990.23. | |
| 2,3-diacetyl-gamma-cyclodextrin | 2,3-Diacetyl-Gamma-Cyclodextrin is a synthesized oligosaccharide used in drug delivery systems. Often employed as a complexing agent, it helps enhance the bioavailability and solubility of poorly water-soluble drugs, advancing pharmacokinetics in therapeutic research. Synonyms: Octakis-(2,3-di-O-acetyl)-γ-cyclodextrin. Molecular formula: C80H112O56. Mole weight: 1969.71. | |
| 2,3-diallyl-gamma-cyclodextrin | 2,3-diallyl-gamma-cyclodextrin is a synthetic compound typically used in the pharmaceutical industry. Acting as a drug deliverer, it has shown efficient encapsulation properties, helping in the transportation and absorption of medications. Synonyms: Octakis-(2,3-di-O-allyl)-γ-cyclodextrin. Molecular formula: C96H144O40. Mole weight: 1938.15. | |
| 2,3-Dimethyl-6-amino-6-deoxy-gamma-cyclodextrin | 2,3-Dimethyl-6-amino-6-deoxy-gamma-cyclodextrin is a chemically modified cyclodextrin, vital in pharmaceutical applications. Its significant role lies in improving bioavailability and stability of drugs, particularly ones with low solubility. Additionally, it shows promise in cargo delivery for gene therapy. Synonyms: Octakis-(2,3-di-O-methyl-6-amino-6-deoxy)-γ-cyclodextrin. Molecular formula: C64H120N8O32. Mole weight: 1513.67. | |
| 2,3-dimethyl-6-deoxy-gamma-cyclodextrin | 2,3-dimethyl-6-deoxy-gamma-cyclodextrin is a pharmaceutical catalyst, magnifing drug solvency and stability masterfully. Synonyms: Octakis-(2,3-di-O-methyl-6-deoxy)-γ-cyclodextrin. Molecular formula: C64H112O32. Mole weight: 1393.55. | |
| 2,3-Dimethyl-6-tert-butyldimethylsilyl-a-cyclodextrin | 2,3-Dimethyl-6-tert-butyldimethylsilyl-a-cyclodextrin is a medicinal chemistry tool, extensively used in the formulation of water-insoluble drugs. It boosts drug solubility and stability, enhancing bioavailability, primarily found beneficial within cancer research. Synonyms: Hexakis-(2,3-di-O-methyl-6-O-tert-butyldimethylsilyl)-a-cyclodextrin. Molecular formula: C84H168O30Si6. Mole weight: 1826.73. | |
| 2,3-Dimethyl-6-tert-butyldimethylsilyl-b-cyclodextrin | 2,3-Dimethyl-6-tert-butyldimethylsilyl-b-cyclodextrin, a compound widely employed in the biomedical field, plays a pivotal role in enhancing drug efficacy through its distinct structural properties. This versatile agent facilitates the solubilization and regulated release of drugs afflicted with poor solubility or instability. Its profound implications extend to formulating treatments for ailments including but not limited to cancer, cardiovascular disorders, and neurodegenerative maladies. Synonyms: 2, 3-Di-O-methyl-6-O-tert-butyldimethylsilyl) cyclomaltoheptaose Heptakis(2,3-di-O-methyl-6-O-tert-butyldimethylsilyl)-b-cyclodextrin. CAS No. 123155-04-4. Molecular formula: C98H196O35Si7. Mole weight: 2131.18. | |
| 2,3-Dimethyl-a-cyclodextrin | 2,3-Dimethyl-a-cyclodextrin is a derivative of cyclodextrin, engaged in the pharmaceutical domain as an operative system for drug conveyance. Through augmentation of both solubility and durability of pharmacological agents, it facilitates enhanced medication administration and efficiency. Synonyms: Hexakis-(2,3-di-O-methyl)-a-cyclodextrin. Molecular formula: C48H84O30. Mole weight: 1141.16. | |
| 2,3-Dimethyl-b-cyclodextrin | 2,3-Dimethyl-b-cyclodextrin is a modified cyclodextrin derivative, used primarily in enhancing drug solubility for therapeutics with low water-solubility. It's often utilized in theresearch of diseases requiring complex medication formulations. Synonyms: Heptakis(2,3-di-O-methyl)-b-cyclodextrin 2,3-Dimethyl-b-cyclodextrin. CAS No. 123155-05-5. Molecular formula: C56H98O35. Mole weight: 1331.36. | |
| 2,3-Dimethyl-cyclodextrin-6-hydrogen sulfate, sodium salt | 2,3-Dimethyl-cyclodextrin-6-hydrogen sulfate, sodium salt, a remarkably versatile compound extensively employed in the field of biomedical research, represents a paramount breakthrough. In its pivotal role as a complexing agent, it unfailingly amplifies the solubility and durability of an array of pharmaceutical compounds. This extraordinary product exhibits unparalleled efficacy when employed in the formulation of drug delivery mechanisms designed to tackle a multitude of debilitating ailments, including but not limited to cancer, cardiovascular afflictions, and neurologic disorders. Synonyms: Heptakis(2,3-di-O-methyl-6-O-sulfo)-b-cyclodextrin heptasodium salt Sodium heptakis(2,3-dimethyl-6-sulfato)-b-cyclodextrin. CAS No. 201346-23-8. Molecular formula: C56H98O56S7. Mole weight: 322.31. | |
| 2,3-Dimethyl-gamma-cyclodextrin | 2,3-Dimethyl-gamma-cyclodextrin is an omnipotent solubilizing entity, escalating the equilibrium and robustness of pharmaceutical compounds. Concurrently, it contributes to amplifying bioavailability in drugs exhibiting suboptimal solubility. Synonyms: Octakis-(2,3-di-O-methyl)-γ-cyclodextrin. Molecular formula: C64H112O40. Mole weight: 1521.55. | |
| 2,3-Di-O-acetyl-6-deoxy-gamma-cyclodextrin | 2,3-Di-O-acetyl-6-deoxy-gamma-cyclodextrin is a type of cyclodextrin widely used in the pharmaceutical industry. It serves as a stabilizer and solubilizing agent for poorly soluble drugs, as well as a delivery system for various bioactive agents. This product has been studied for its potential use in treating various diseases, including cancer and Alzheimer's disease. Synonyms: Octakis-(2,3-di-O-acetyl-6-deoxy)-γ-cyclodextrin. Molecular formula: C80H112O48. Mole weight: 1841.72. | |
| 2,3-di-O-acetyl-6-O-tert-butyldimethylsilyl-gamma-cyclodextrin | 2,3-di-O-acetyl-6-O-tert-butyldimethylsilyl-gamma-cyclodextrin is a modified cyclodextrin used in enhancing the solubility and stability of drugs, improving their bioavailability. It is often employed in developing formulations for poorly soluble drugs. Synonyms: Octakis-(2,3-di-O-acetyl-6-O-tert-butyldimethylsilyl)-γ-cyclodextrin. Molecular formula: C12H224O56SI8. Mole weight: 2313.18. | |
| 2,3-Di-O-acetyl-a-cyclodextrin | 2,3-Di-O-acetyl-a-cyclodextrin is mainly used to increase the solubility and stability of drugs. Its specialized structure is capable of forming inclusion complexes with various compounds, enhancing their bioavailability. Notably applied in the design of improved drug delivery systems. Synonyms: Hexakis-(2,3-di-O-acetyl)-a-cyclodextrin. Molecular formula: C60H84O42. Mole weight: 1477.28. | |
| 2,3-Di-O-acetyl-b-cyclodextrin | 2,3-Di-O-acetyl-b-cyclodextrin is a derivative of beta-cyclodextrin, used in the biomedical industry for drug delivery systems. It enhances the soluble property of poorly water-soluble drugs, aiding in their absorption and distribution. Synonyms: Heptakis-(2,3-di-O-acetyl)-b-cyclodextrin. Molecular formula: C70H98O49. Mole weight: 1723.50. | |
| 2,3-Di-O-acetyl-gamma-cyclodextrin | 2, 3-Di-O-acetyl-gamma-cyclodextrin, an invaluable compound, finds extensive application in the biomedical industry. Its role lies in elevating the solubility and stability of drugs, rendering it indispensable in pharmaceutical formulations. By virtue of its exceptional encapsulation capabilities, it facilitates enhanced drug delivery systems and targeted therapy. Synonyms: Octakis-(2,3-di-O-acetyl)-γ-cyclodextrin. Molecular formula: C80H112O56. Mole weight: 1969.71. | |
| 2,3-Di-O-allyl-a-cyclodextrin | 2,3-Di-O-allyl-a-cyclodextrin is a biomedical substance used in drug delivery due to its exceptional encapsulation capability. It's primarily utilized in the formulation of hydrophobic drugs, improving their solubility and bioavailability, thus enhancing therapeutic effectiveness. Synonyms: Hexakis-(2,3-di-O-allyl)-a-cyclodextrin. Molecular formula: C72H108O30. Mole weight: 1453.61. | |
| 2,3-Di-O-allyl-b-cyclodextrin | 2,3-Di-O-allyl-b-cyclodextrin is a modified cyclodextrin used to enhance drug delivery. It's primarily used in pharmaceuticals to improve solubility and stability of poorly soluble drugs, facilitating more efficient drug absorption and increasing their therapeutic efficacy. Synonyms: Heptakis-(2,3-di-O-allyl)-b-cyclodextrin. Molecular formula: C84H126O35. Mole weight: 1695.88. | |
| 2,3-Di-O-benzoyl-a-cyclodextrin | 2,3-Di-O-benzoyl-a-cyclodextrin is a pharmaceutical excipient often used in drug formulation. It enhances the solubility of poorly water-soluble drugs, improving their effectiveness and bioavailability. It is used widely in the research of various diseases. Molecular formula: C120H108O42. Mole weight: 2222.12. | |
| 2,3-di-O-benzyl-6-O-tert-butyldimethylsilyl-gamma-cyclodextrin | 2,3-di-O-benzyl-6-O-tert-butyldimethylsilyl-gamma-cyclodextrin is a modified cyclodextrin used in the formation of complex structures for the delivery of various drugs. Specifically, it assists in improving the solubility and bioavailability of poorly soluble pharmaceuticals. Synonyms: Octakis-(2,3-di-O-benzyl-6-O-tert-butyldimethylsilyl)-γ-cyclodextrin. Molecular formula: C208H288O40SI8. Mole weight: 4475.79. | |
| 2,3-Di-O-benzyl-a-cyclodextrin | 2,3-Di-O-benzyl-a-cyclodextrin is a versatile carrier for various drugs due to its unique structure. It is utilized in designing drug delivery systems and enhancing solubility of poorly soluble drugs, thereby improving their bioavailability. Synonyms: Hexakis-(2,3-di-O-benzyl)-a-cyclodextrin. Molecular formula: C120H132O30. Mole weight: 2054.31. | |
| 2,3-Di-O-benzyl-b-cyclodextrin | 2,3-Di-O-benzyl-b-cyclodextrin is a modified cyclodextrin primarily used in the pharmaceutical industry. Its unique structure increases drug solubility and stability. Synonyms: Heptakis-(2,3-di-O-benzyl)-b-cyclodextrin. Molecular formula: C140H154O35. Mole weight: 2396.70. | |
| 2,3-di-O-methyl-6-O-tert-butyldimethylsilyl-gamma-cyclodextrin | 2,3-di-O-methyl-6-O-tert-butyldimethylsilyl-gamma-cyclodextrin is primarily utilized as a chiral selective medium in pharmaceutical research. It aids in the separation of drug stereoisomers, thereby optimizing therapeutic effectiveness and minimizing side effects.". Synonyms: Octakis-(2,3-di-O-methyl-6-O-tert-butyldimethylsilyl)-γ-cyclodextrin. Molecular formula: C112H224O40SI8. Mole weight: 3258.25. | |
| 2,6-Diethyl-b-cyclodextrin | 2,6-Diethyl-b-cyclodextrin, an essential and widely used cyclodextrin derivative in biomedicine, serves as an effective solubilizer and stabilizer for poorly water-soluble drugs, intensifying their bioavailability and efficacy to a great extent. Additionally, recent research has shown its therapeutic potential for treating diseases, such as cancer, inflammation, and viral infections, making it an incredibly promising and crucial ingredient in the biomedicine industry. Synonyms: Heptakis-(2,6-di-O-ethyl)-b-cyclodextrin. CAS No. 111689-03-3. Molecular formula: C70H126O35. Mole weight: 1527.73. | |
| 2,6-Dimethyl-a-cyclodextrin | 2,6-Dimethyl-α-cyclodextrin is a highly versatile compound extensively utilized in the biomedical arena, serving as an efficacious excipient that meritoriously augments the solubility and stability of hydrophobic pharmaceutical agents. Synonyms: Hexakis-(2,6-di-O-methyl)-a-cyclodextrin. Molecular formula: C48H84O30. Mole weight: 1141.16. | |
| 2,6-Dimethyl-β-cyclodextrin | 2,6-Dimethyl-β-cyclodextrin is a β-cyclodextrin derivative with enhanced water solubility. It can be used as a solubilizer and stabilizer in pharmaceutical preparations. It can effectively dissolve lipophilic drugs such as steroid hormones, vitamins A, E and K to improve the solubility and bioavailability of weakly hydrophilic drug compounds. Synonyms: 2,6-Di-O-methyl-beta-cyclodextrin; Heptakis(2,6-di-O-methyl)-beta-cyclodextrin. CAS No. 51166-71-3. Molecular formula: C56H98O35. Mole weight: 1331.36. | |
| 2,6-dimethyl-gamma-cyclodextrin | 2,6-Dimethyl-gamma-cyclodextrin is a versatile compound widely used to enhance drug solubility and stability for improved bioavailability. This cyclodextrin derivative has shown promise in the research of various diseases, including Alzheimer's, cancer, and cardiovascular disorders, where it acts as a carrier molecule for targeted drug delivery. Its unique chemical structure allows it to encapsulate hydrophobic molecules, making it an invaluable tool in pharmaceutical research and development. Synonyms: Octakis-(2,6-di-O-methyl)-γ-cyclodextrin. Molecular formula: C64H112O40. Mole weight: 1521.55. | |
| 2,6-di-n-pentyl-gamma-cyclodextrin | 2,6-di-n-pentyl-gamma-cyclodextrin is a versatile inclusion complexing agent used in the biomedical industry. It plays a vital role in drug delivery systems by encapsulating hydrophobic drugs. With its unique structure, it enhances solubility and stability of drugs. Synonyms: Octakis-(2,6-di-O-n-pentyl)-γ-cyclodextrin. Molecular formula: C128H240O40. Mole weight: 2419.25. | |
| (2,6-Di-O-)ethyl-β-cyclodextrin | (2,6-Di-O-)ethyl-β-cyclodextrin. Group: Polysaccharide. | |
| 2,6-di-O-methyl-3-O-n-pentyl-gamma-cyclodextrin | 2,6-di-O-methyl-3-O-n-pentyl-gamma-cyclodextrin is a derivative of cyclodextrin with encapsulation properties offering promising potential as a drug delivery agent. Through strategic structural modifications, solubility, stability, and bioavailability of drugs witness a remarkable surge, ultimately elevating their therapeutic efficacy. Synonyms: Octakis-(2,6-di-O-methyl-3-O-n-pentyl)-γ-cyclodextrin. Molecular formula: C104H192O40. Mole weight: 2082.61. | |
| 2,6-Di-O-methyl-beta-cyclodextrin | 2,6-Di-O-methyl-beta-cyclodextrin. Group: Macrocycles. Alternative Names: DIMETHYL BETA-CYCLODEXTRIN; DIMEB; HEPTAKIS(2,6-DI-O-METHYL)-BETA-CYCLODEXTRIN; 2,6-DI-O-METHYL-BETA-CYCLODEXTRIN; 6(supa), 6(supb), 6(supc), 6(supd), 6(supe), 6(supf), 6(supg)-tetradeca-o-g; beta-cyclodextrin, 2(supa), 2(supb), 2(supc), 2(supd), 2(supe), 2(supf), 2(sup; heptakis(2,6-o-dimethyl)beta-cyclodextrin; HEPTAKIS(2,6-DI-O-METHYL)-B-*CYCLODEXTRI N. CAS No. 51166-71-3. Molecular formula: 1331.36. Mole weight: C56< / sub>H98< / sub>O35< / sub>. | |
| 2,6-di-O-n-pentyl-3-O-acetyl-gamma-cyclodextrin | 2,6-di-O-n-pentyl-3-O-acetyl-gamma-cyclodextrin is a compound represents a modified derivative of cyclodextrin. Serving as a highly effective mechanism for drug delivery, it profoundly amplifies the solubility and durability of hydrophobic drugs. Its diverse applications encompass the research of a myriad of diseases, notably cancer, cardiovascular maladies, as well as neurodegenerative disorders. Synonyms: Octakis-(2,6-di-O-n-pentyl-3-O-acetyl)-γ-cyclodextrin. Molecular formula: C144H256O48. Mole weight: 2755.54. | |
| 2,6-di-O-n-pentyl-3-O-n-butyryl-gamma-cyclodextrin | 2,6-di-O-n-pentyl-3-O-n-butyryl-gamma-cyclodextrin is a biomedical compound with the application in revolutionizing drug delivery systems. Its multifaceted attributes encompass augmenting drug solubility, bolstering stability, and elevating bioavailability. Synonyms: Octakis-(2,6-di-O-n-pentyl-3-O-n-butyryl)-γ-cyclodextrin. Molecular formula: C160H288O48. Mole weight: 2979.97. | |
| 2,6-di-O-n-pentyl-3-O-trifluroacetyl-gamma-cyclodextrin | 2,6-di-O-n-pentyl-3-O-trifluroacetyl-gamma-cyclodextrin is a versatile compound with strong drug-delivery properties, enhancing the solubility and stability of various drugs. Additionally, it shows promising potential in treating diseases such as cancer, Alzheimer's, and cardiovascular disorders by facilitating targeted drug delivery and improving therapeutic efficacy. Synonyms: Octakis-(2,6-di-O-n-pentyl-3-O-trifluoroacetyl)-γ-cyclodextrin. Molecular formula: C144H232F24O48. Mole weight: 3187.32. | |
| 2,6-Di-O-tert-butyldimethylsilyl)-b-cyclodextrin | 2,6-Di-O-tert-butyldimethylsilyl)-b-cyclodextrin is an excipient in drug formulation to enhance drug solubility and stability. This compound aids in the development of various diseases by improving drug delivery efficiency, particularly for poorly soluble drugs. Synonyms: Heptakis-(2,6-di-O-tert-butyldimethylsilyl)-b-cyclodextrin 2,6-Di-TBDMS-b-cyclodextrin. CAS No. 84346-53-2. Molecular formula: C126H266O35Si14. Mole weight: 2734.64. | |
| 2,6-di-tert-butyldimethylsilyl-gamma-cyclodextrin | 2,6-di-tert-butyldimethylsilyl-gamma-cyclodextrin is a versatile biomaterial employed to enhance the solubility and stability of pharmaceutical drugs, especially hydrophobic compounds. This advanced cyclodextrin derivative shows immense potential in the drug development of various diseases by improving drug delivery, prolonging drug release, and increasing drug efficacy. Synonyms: Octakis-(2,6-di-O-tert-butyldimethylsilyl)-γ-cyclodextrin. Molecular formula: C144H304O40Si16. Mole weight: 3125.30. | |
| (2-Carboxyethyl)-a-cyclodextrin | (2-Carboxyethyl)-a-cyclodextrin is a versatile cyclodextrin derivative employed in creating drug delivery systems. Its unique structure enhances solubility and stability of pharmaceutical agents, used for research of enhancing efficacy in cancer therapeutics and treating neurodegenerative disorders. Synonyms: (2-Carboxyethyl)-alpha-cyclodextrin; (2-Carboxyethyl)-α-cyclodextrin; CEACD. Molecular formula: C36H60-nO30·(CH2CH2COOH)n. | |
| (2-Carboxyethyl)-b-cyclodextrin | (2-Carboxyethyl)-b-cyclodextrin is a vital component in the biomedical industry. It is extensively used as an excipient or carrier for drugs, enabling improved drug solubility and stability. This innovative compound finds applications in targeted drug delivery systems and pharmaceutical formulations. Synonyms: CEBCD; (2-Carboxyethyl)-b-cyclodextrin sodium salt. Grades: 95%. Molecular formula: C42H70-nO35·(C2H4COONa)n. Mole weight: 1135.0+n(94.1). | |
| (2-Carboxyethyl)-b-cyclodextrin solium salt | (2-Carboxyethyl)-b-cyclodextrin sodium salt is a pharmaceutical excipient used to enhance the solubility and stability of drugs. It's particularly effective for hydrophobic drugs, improving absorption and bioavailability. Synonyms: (2-Carboxyethyl)-beta-cyclodextrin solium salt; (2-Carboxyethyl)-β-cyclodextrin solium salt; CEBCD. Molecular formula: C42H70-nO35·(CH2CH2COONa)n. | |
| (2-Carboxyethyl)-gamma-cyclodextrin | (2-Carboxyethyl)-gamma-cyclodextrin is a biomedicine utilized in the pharmaceutical industry. It is commonly used as a drug delivery system due to its unique structure that enables the encapsulation of hydrophobic drugs. This product plays a crucial role in improving the solubility and stability of these drugs, increasing their bioavailability for the treatment of various diseases. Synonyms: (2-Carboxyethyl)-γ-cyclodextrin. Molecular formula: C48H80-nO40·(CH2CH2COOH)n. | |
| (2-Hydroxy-3-N,N,N-trimethylamino)propyl-alpha-cyclodextrin chloride | (2-Hydroxy-3-N,N,N-trimethylamino)propyl-alpha-cyclodextrin chloride is a consequential pharmaceutical mediating factor ubiquitously used within biomedical sectors. It accentuates the physicochemical characteristics of medicinal substances, amplifies drug stability, and potentially elevates drug dispersal and formulation methodologies aimed at treating assorted diseases. Molecular formula: C36H60-nO30·(C6H15ONCl)n. | |
| (2-Hydroxy-3-N,N,N-trimethylamino)propyl-beta-cyclodextrin chloride | (2-Hydroxy-3-N,N,N-trimethylamino)propyl-beta-cyclodextrin chloride is a molecular carrier typically used in biomedical applications. Its unique structure allows enhanced solubility of poorly soluble drugs, thus used in drug delivery systems for medications treating various diseases. Molecular formula: C42H70-nO35·(C6H15ONCl)n. | |
| (2-Hydroxy-3-N,N,N-trimethylamino)propyl-gamma-cyclodextrin chloride | (2-Hydroxy-3-N,N,N-trimethylamino)propyl-gamma-cyclodextrin chloride is a vital compound in the biomedical industry. It is used as a carrier molecule for pharmaceutical drugs, specifically those targeting diseases of the central nervous system. With its unique structural features, this cyclodextrin derivative enhances drug solubility, stability, and bioavailability, ultimately improving therapeutic efficacy for various neurological disorders. Molecular formula: C48H80-nO40·(C6H15ONCl)n. | |
| (2-Hydroxyethyl)-b-cyclodextrin | (2-Hydroxyethyl)-β-cyclodextrin is a derivative of β-cyclodextrin, which can help improve the solubility of the drug in oral preparations or preparations. Synonyms: Hydroxyethyl beta-cyclodextrin; B-Cyclodextrin, 2-hydroxyethyl ethers. CAS No. 128446-32-2. Molecular formula: C56H98O42. Mole weight: 1443.358. | |
| (2-Hydroxypropyl)-a-cyclodextrin | (2-Hydroxypropyl)-α-cyclodextrin is a widely used pharmaceutical excipient. It improves the solubility and bioavailability of poorly soluble drugs, enhancing their delivery. It's utilized in several drug formulations to advance research of treating diseases like cancer, fungal infections, and cardiovascular disorders. Synonyms: 5, 10, 15, 20, 25, 30-Hexakis(2-hydroxypropoxymethyl)-2, 4, 7, 9, 12, 14, 17, 19, 22, 24, 27, 29-dodecaoxaheptacyclo[26.2.2.23, 6.28, 11.213, 16.218, 21.223, 26]dotetracontane-31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42-dodecol; 99241-24-4; alpha-Cyclodextrin, 2-hydroxypropyl ethers; Hydroxypropyl-alpha-cyclodextrin (DS~4.5); FT-0627159. CAS No. 128446-33-3. Molecular formula: C54H96O36. Mole weight: 1180. | |
| (2-Hydroxy)propyl-α-cyclodextrin | (2-Hydroxy)propyl-α-cyclodextrin is a versatile compound commonly used in the biomedical industry. It acts as a solubilizing agent and drug delivery system for poorly soluble drugs, enhancing their bioavailability and therapeutic outcomes. Additionally, it finds applications in gene therapy, providing stability and protection to nucleic acids against enzymatic degradation. Synonyms: (2-Hydroxy)propyl-alpha-cyclodextrin; Hydroxypropyl-alpha-cyclodextrin. CAS No. 99241-24-4. Molecular formula: C36H60-nO30·(C3H7O)n. Mole weight: 1321.3. | |
| 2-Hydroxypropyl-b-cyclodextrin | 2-Hydroxypropyl-b-cyclodextrinis a β-cyclodextrin derivative with enhanced water solubility. It can be used as a solubilizer and stabilizer in pharmaceutical preparations. Synonyms: 2-Hydroxypropyl-β-cyclodextrin. CAS No. 128446-35-5. Molecular formula: (C6H9O5)7(C3H7O)n. Mole weight: 1541.5. | |
| 2-Hydroxypropyl-b-cyclodextrin - Rhodamine labelled | | |
| (2-Hydroxypropyl)-beta-cyclodextrin | DryPowder; Liquid. Group: Macrocycles. CAS No. 128446-35-5. Product ID: (1R, 3S, 5S, 6R, 8S, 10S, 11R, 13S, 15S, 16R, 18S, 20S, 21R, 23S, 25S, 26R, 28S, 30S, 31R, 33S, 35S, 36S, 37S, 38S, 39S, 40S, 41S, 42S, 43S, 44S, 45S, 46S, 47S, 48S, 49S)-5, 10, 15, 20, 25, 30, 35-heptakis(2-hydroxypropoxymethyl)-2, 4, 7, 9, 12, 14, 17, 19, 22, 24, 27, 29, 32, 34-tetradecaoxaoctacyclo[31.2.2.23, 6.28, 11.213, 16.218, 21.223, 26.228, 31]nonatetracontane-36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49-tetradecol. Molecular formula: 1541.5g/mol. Mole weight: C63H112O42. CC (COCC1C2C (C (C (O1)OC3C (OC (C (C3O)O)OC4C (OC (C (C4O)O)OC5C (OC (C (C5O)O)OC6C (OC (C (C6O)O)OC7C (OC (C (C7O)O)OC8C (OC (O2)C (C8O)O)COCC (C)O)COCC (C)O)COCC (C)O)COCC (C)O)COCC (C)O)COCC (C)O)O)O)O. InChI=1S/C63H112O42/c1-22 (64)8-85-15-29-50-36 (71)43 (78)57 (92-29)100-51-30 (16-86-9-23 (2)65)94-59 (45 (80)38 (51)73)102-53-32 (18-88-11-25 (4)67)96-61 (47 (82)40 (53)75)104-55-34 (20-90-13-27 (6)69)98-63 (49 (84)42 (55)77)105-56-35 (21-91-14-28 (7)70)97-62 (48 (83)41 (56)76)103-54-33 (19-89-12-26 (5)68)95-60 (46 (81)39 (54)74)101-52-31 (17-87-10-24 (3)66)93-58 (99-50)44 (79)37 (52)72/h22-84H, 8-21H2, 1-7H3/t22?, 23?, 24?, 25?, 26?, 27?, 28?, 29-, 30-, 31-, 32-, 33-, 34-, 35-, 36-, 37-, 38-, 39-, 40-, 41-, 42-, 43-, 44-, 45-, 46-, 47-, 48-, 49-, 50-, 51-, 52-, 53-, 54-, 55-, 56-, 57-, 58-, 59-, 60-, 61-, 62-, 63-/m0/s1. ODLHGICHYURWBS-FOSI | |
| 2-Hydroxypropyl- β-cyclodextrin | 2-Hydroxypropyl- β-cyclodextrin. Group: Biochemicals. Grades: Purified. CAS No. 128446-35-5. Pack Sizes: 1g. US Biological Life Sciences. |  Worldwide |
| 2-Hydroxypropyl-β-cyclodextrin | 2-Hydroxypropyl-β-cyclodextrin. CAS No. 128446-35-5. Product ID: CDC10-0091. Molecular formula: C63H112O42. Category: Cosmetic Chelating Chemicals. Product Keywords: Cosmetic Ingredients; Cosmetic Chelating Chemicals; 2-Hydroxypropyl-β-cyclodextrin; CDC10-0091; 128446-35-5; C63H112O42; 420-920-1; 128446-35-5. Color: White to slightly yellow. EC Number: 420-920-1. Physical State: Solution. Solubility: H2O: 45 % (w/v). Melting Point: 278 °C (dec.). | |
| 2-Hydroxypropyl-beta-cyclodextrin | 25g Pack Size. Group: Biochemicals, Carbohydrates, Stains & Indicators. Formula: N/A. CAS No. 128446-35-5. Prepack ID 44405595-25g. Molecular Weight 1400 Average. See USA prepack pricing. |  |
| (2-Hydroxypropyl)-γ-cyclodextrin | (2-Hydroxypropyl)-γ-cyclodextrin. CAS No. 128446-34-4. Product ID: CDC10-0092. Category: Cosmetic Chelating Chemicals. Product Keywords: Cosmetic Ingredients; Cosmetic Chelating Chemicals; (2-Hydroxypropyl)-γ-cyclodextrin; CDC10-0092; 128446-34-4; 207-166-5; 128446-34-4. Color: White. EC Number: 207-166-5. Physical State: Solid Powder. Solubility: H2O: soluble 450 mg/mL. Quality Level: 100. Storage: Room temp. Boiling Point: 97-98 °C3 mm Hg(lit.). Melting Point: 52-55 °C(lit.). | |
| (2-Hydroxypropyl)-gamma-cyclodextrin | (2-Hydroxypropyl)-gamma-cyclodextrin is a water-soluble alkylated cyclodextrin derivative. It can help improve the solubility of the drug in oral preparations or preparations. (2-Hydroxypropyl)-gamma-cyclodextrin is used for the dissolution of macromolecules and cell culture applications. (2-Hydroxypropyl)-gamma-cyclodextrin has been used to study its inhibitory effect on complement products and the inflammation induced by cholesterol crystals (CC) in plasma samples. Synonyms: 2-hydroxypropyl Ethers γ-Cyclodextrin; HGC. CAS No. 128446-34-4. Molecular formula: C7H6FNO2. Mole weight: 155.13. | |
| (2-Hydroxypropyl)-γ-cyclodextrin (Technical Grade) | (2-Hydroxypropyl)-γ-cyclodextrin is used in sthe solubilization of macromolecules and in cell culture applications. Similar to β-Cyclodextrin (C987830), however can work with larger molecules. Group: Biochemicals. Grades: Purified. CAS No. 128446-34-4. Pack Sizes: 1g, 5g. Molecular Formula: N/A. US Biological Life Sciences. | Worldwide |
| 3,6-diacetyl-gamma-cyclodextrin | 3,6-Diacetyl-gamma-cyclodextrin is a compound widely employed in the biomedical sector, exhibiting remarkable versatility. Functioning as a carrier compound for sundry pharmacological agents, it augments their solubility and bioavailability. The derivative of cyclodextrin offers great potential in the realm of disease research, particularly cancer, as it enhances the efficiency and transportation of anticancer compounds. Synonyms: Octakis-(3,6-di-O-methyl)-γ-cyclodextrin. Molecular formula: C80H112O56. Mole weight: 1969.71. | |
| 3,6-Dimethyl-a-cyclodextrin | 3,6-Dimethyl-a-cyclodextrin is a powerful tool in the biomedical industry used to enhance drug delivery and solubility. It effectively improves the bioavailability and stability of drugs, making it ideal for reserch of a range of diseases. With its unique structure, this compound is highly versatile in encapsulating and delivering various pharmaceuticals. Synonyms: Hexakis-(3,6-di-O-methyl)-a-cyclodextrin. Molecular formula: C48H84O30. Mole weight: 1141.16. | |
| 3,6-Di-O-acetyl-a-cyclodextrin | 3,6-Di-O-acetyl-a-cyclodextrin is a remarkable and multifaceted compound, standing at the forefront of drug delivery systems and pharmaceutical formulations. As a solubilizer and stabilizer, it ingeniously amplifies the solubility and bioavailability of drugs, successfully tackling the challenge posed by poorly water-soluble counterparts. Synonyms: Hexakis-(3,6-di-O-acetyl)-a-cyclodextrin. Molecular formula: C60H84O42. Mole weight: 1477.28. | |
Our database is helping our users find suppliers everyday.
